Stereotaxis Inc - רווח נקי למניה אחת בשנים עשר החודשים האחרונים STXS

Stereotaxis, Inc. (STXS) develops high-tech solutions for cardiac surgery. This price chart reflects the EPS TTM trend, which currently stands at 15.80. Complex patents and the specifics of physician training create a high level of clinic dependency on the company's products. Profit is generated through the sale of Genesis navigation systems and associated consumables. Business stability is bolstered by a loyal engineering staff and the active recruitment of programmers.

Stereotaxis, Inc. (STXS) is developing high-tech magnetic navigation systems through strategic alliances with cardiac centers and catheter manufacturers. The efficiency of these partnerships is reflected in the annual dynamics of the EPS TTM, which measures the percentage change in net income per share over the last twelve months relative to the previous year. This vector allows for the separation of temporary fluctuations from sustainable fundamental business growth. Analysis of this metric determines whether the current market cost of capital is justified by the pace of profit scaling.